AnaptysBio, Inc.
AnaptysBio, Inc. (ANAB) Stock Overview
Explore AnaptysBio, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.9B
P/E Ratio
-136.85
EPS (TTM)
$-0.46
ROE
18.14%
ANAB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AnaptysBio, Inc. (ANAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 66.14, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $38.50.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -136.85 and a market capitalization of 1.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.